Detalles de la búsqueda
1.
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.
Eur J Clin Pharmacol
; 77(9): 1297-1307, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33660020
2.
Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjects.
Pharm Res
; 31(7): 1813-22, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24469906
3.
Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment.
Ther Drug Monit
; 36(2): 192-201, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24632753
4.
Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy.
Med Microbiol Immunol
; 202(2): 117-24, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22983722
5.
Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.
Clin Infect Dis
; 52(1): 122-7, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21148530
6.
Sequential population pharmacokinetic modeling of lopinavir and ritonavir in healthy volunteers and assessment of different dosing strategies.
Antimicrob Agents Chemother
; 55(6): 2775-82, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21422211
7.
Evaluation of Platelet Activation by HIV Protease Inhibitors - The HIV-PLA II Study.
HIV AIDS (Auckl)
; 13: 789-800, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34393518
8.
Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir.
J Antimicrob Chemother
; 65(5): 999-1004, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20202988
9.
Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
Transfusion
; 50(2): 354-60, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19788511
10.
Higher pain scores, similar opioid doses and side effects associated with antipyretic analgesics in specialised tertiary pain care.
Inflamm Res
; 59(11): 989-95, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20490889
11.
Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting.
Eur J Clin Pharmacol
; 66(4): 375-81, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20033681
12.
Cytochrome P450 3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in human immunodeficiency virus type 1-infected adults.
Antimicrob Agents Chemother
; 53(8): 3524-7, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19528289
13.
Decrease of atazanavir and lopinavir plasma concentrations in a boosted double human immunodeficiency virus protease inhibitor salvage regimen.
Antimicrob Agents Chemother
; 52(6): 2273-5, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18411323
14.
Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.
Antivir Ther
; 13(8): 1039-46, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19195329
15.
Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo.
J Antimicrob Chemother
; 61(2): 394-9, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18156609
16.
The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.
J Antimicrob Chemother
; 62(3): 579-82, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18477709
17.
Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
J Antimicrob Chemother
; 62(5): 1118-21, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18753189
18.
Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients.
Antivir Ther
; 12(8): 1237-46, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18240863
19.
Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
J Clin Pharmacol
; 47(11): 1398-407, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17873238
20.
Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults.
Eur J Clin Pharmacol
; 63(10): 935-40, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17665183